Clinical trial
Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of…
NCT00376285 · Pfizer, Industry · Withdrawn
Key facts
| NCT number | NCT00376285 |
|---|---|
| Title | Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033 |
| Official title | A Phase 1, Randomized, Investigator and Subject Blind, Sponsor Open Study to Determine the Effects of Fenofibrate on the Safety, Toleration and Efficacy Biomarkers of CP-742,033 When Co-Administered in Otherwise Healthy Obese Adult Subjects |
| Lead sponsor | Pfizer, Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | CP-742, 033, Fenofibrate |
| Enrollment | 0 |
| Start date | Nov 1, 2006 |
| First posted | Sep 14, 2006 |
| Last update posted | Apr 22, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: